CHARLEY LANE: Open Payments
NPI 1437595659 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 29 payments from 14 companies in 2025. Trend: 2023 $138 · 2024 $922 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| Lilly USA, LLC | 5 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Abbott Laboratories | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: VRAYLAR, MOUNJARO, Kerendia, Ozempic, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
